2020
DOI: 10.1097/01.ccm.0000727112.58380.5e
|View full text |Cite
|
Sign up to set email alerts
|

306: Low-Molecular-Weight Heparin Dosing and Anti-Xa Level Monitoring in Critically Ill COVID-19 Adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance